ViewsML
Medical Imaging Systems · Medical AI
Overview
Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
Funding and backers
Total raised
$4.9M
1 round on record
Latest round
$4.9M
Seed · Apr 2026 · 6 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 20
Raised a round Seed $4.9M
Aug 18, 2025
Partnership Viewsml And Iprocess Announce Strategic Partnership To Accelerate Delivery Of AI-Powered Virtual Biomarker Testing · menafn
Jun 17, 2025
Partnership ViewsML and Debiopharm Collaborate to Advance Virtual Biomarker Technology in Drug Research · EIN Presswire
May 6, 2025
Expanded ViewsML Expands to Asia Pacific, In-Licensing Technology from ASTAR · EIN Presswire
Apr 8, 2025
Partnership ViewsML and Dartmouth Health Partner to Advance AI-Driven Virtual Biomarkers and Diagnostics · wkrg.com
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Apr 2026 | $4.9M | — | debiopharm.com |
Investors in similar startupsfunds that back the companies most like this one
backs Lily MedTech, Quibim
Similar startupsby what they do, their industry and backers
4DMedical develops software that turns standard lung scans into quantitative airflow imaging. Its technology reveals regional ventilation…
Shukun Technology builds medical imaging artificial intelligence for cardiovascular, neurological and oncology diagnosis in Chinese…
AZmed builds artificial intelligence that detects fractures and lesions on radiographs. Its Rayvolve software supports emergency radiology…
Quibim is a Valencian medical imaging company founded in 2012 and specialised in quantitative image biomarkers. Its algorithms extract…
Vara is a Berlin company founded in 2018 that builds artificial intelligence for breast cancer screening. Its software reads mammograms to…
Digital pathology and remote diagnostics solutions for hospitals, laboratories and research centers. Improve workflows, enable real-time…
Financials
Total raised
$4.9M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2026 | $4.9M | Details |
News
Advancing made-in-B.C. health technology to strengthen patient care
Funding will help homegrown companies pilot new tech to strengthen economic resilience in B.C.
Read more
Report
ViewsML: $4.9 Million Seed Funding Raised To Commercialize AI-Powered Virtual Biomarker Staining Platform
ViewsML announced it has raised $4.9 million in an oversubscribed seed funding round to accelerate commercialization of its virtual biomarker staining platform. The round was led by Wittington Ventures, with participation from Continuum Health Ventures an
Read more
Report
ViewsML Raises $4.9M for AI-Driven Virtual Biomarker Staining Platform
ViewsML secures a $4.9M seed round backed to replace physical pathology lab staining with AI-driven virtual biomarkers.
Read more
Report
ViewsML secures $4.9 million to help scientists virtually analyze tissue samples
Wittington, Mayo Clinic back startup's plan to build world's first virtual biomarker library. The post ViewsML secures $4.9 million to help scientists virtually analyze tissue samples first appeared on BetaKit.
Read more
Report
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscrib
Read more
Report
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- ViewsML, a company building the computational layer for biomarker discovery by...
Read more
Report
Viewsml And Iprocess Announce Strategic Partnership To Accelerate Delivery Of AI-Powered Virtual Biomarker Testing
Viewsml And Iprocess Announce Strategic Partnership To Accelerate Delivery Of AI-Powered Virtual Biomarker Testing.ViewsML TechnologiesiProcess Global ResearchPartnership brings ViewsML
Read more
Report
ViewsML and Debiopharm Collaborate to Advance Virtual Biomarker Technology in Drug Research
Debiopharm taps ViewsML's AI-driven platform to streamline biomarker detection in oncology research.
Read more
Report
ViewsML Expands to Asia Pacific, In-Licensing Technology from ASTAR
ViewsML expands to Singapore with ASTAR tech licensing agreement to enhance AI-powered virtual biomarker platform
Read more
Report